Bicycle Therapeutics plc (BCYC) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
37/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseBCYC / S&P -8.62% / 15.20% |
WinBCYC / S&P 217.44% / 15.00% |
LoseBCYC / S&P -22.22% / 50.40% |
| 2026-Q11/3 |
LoseBCYC / S&P -34.46% / -4.33% |
WinBCYC / S&P 146.85% / 11.30% |
LoseBCYC / S&P 0.32% / 27.70% |
| 2025-Q41/3 |
LoseBCYC / S&P -8.53% / 2.65% |
WinBCYC / S&P 105.77% / 9.00% |
LoseBCYC / S&P 9.72% / 13.40% |
| 2025-Q31/3 |
WinBCYC / S&P 11.37% / 8.12% |
LoseBCYC / S&P -23.20% / 4.61% |
LoseBCYC / S&P 11.04% / 13.45% |
| 2025-Q20/3 |
LoseBCYC / S&P -18.14% / 10.94% |
LoseBCYC / S&P -51.28% / 4.83% |
LoseBCYC / S&P -7.14% / 10.63% |
| 2025-Q10/3 |
LoseBCYC / S&P -39.36% / -4.27% |
LoseBCYC / S&P -38.18% / 4.98% |
LoseBCYC / S&P -28.96% / 10.57% |
| 2024-Q41/3 |
LoseBCYC / S&P -38.14% / 2.41% |
WinBCYC / S&P 30.76% / 5.25% |
LoseBCYC / S&P -43.53% / 6.15% |
| 2024-Q32/3 |
WinBCYC / S&P 11.81% / 5.89% |
WinBCYC / S&P 48.60% / 5.89% |
LoseBCYC / S&P -34.54% / 6.11% |
| 2024-Q21/3 |
LoseBCYC / S&P -18.71% / 4.28% |
WinBCYC / S&P 75.74% / 5.38% |
LoseBCYC / S&P -19.23% / 5.12% |
| 2024-Q13/3 |
WinBCYC / S&P 37.72% / 10.56% |
WinBCYC / S&P 168.47% / 5.71% |
WinBCYC / S&P 6.00% / 5.59% |
| 2023-Q42/3 |
LoseBCYC / S&P -10.00% / 11.69% |
WinBCYC / S&P 86.52% / 6.81% |
WinBCYC / S&P 34.21% / 7.78% |
| 2023-Q32/3 |
LoseBCYC / S&P -21.28% / -3.27% |
WinBCYC / S&P 64.99% / 7.52% |
WinBCYC / S&P 46.47% / -5.03% |
| 2023-Q23/3 |
WinBCYC / S&P 19.98% / 8.74% |
WinBCYC / S&P 37.79% / 9.50% |
WinBCYC / S&P 54.46% / -8.57% |
| 2023-Q12/3 |
LoseBCYC / S&P -28.14% / 7.50% |
WinBCYC / S&P 12.73% / 10.77% |
WinBCYC / S&P 45.30% / -15.69% |
| 2022-Q43/3 |
WinBCYC / S&P 27.26% / 7.56% |
WinBCYC / S&P 23.65% / 11.88% |
WinBCYC / S&P 42.32% / -17.99% |
| 2022-Q33/3 |
WinBCYC / S&P 38.62% / -4.88% |
WinBCYC / S&P 27.82% / 13.47% |
WinBCYC / S&P 16.84% / -1.41% |
| 2022-Q21/3 |
LoseBCYC / S&P -61.76% / -16.10% |
WinBCYC / S&P 44.84% / 13.71% |
LoseBCYC / S&P 6.69% / 11.04% |
| 2022-Q11/3 |
LoseBCYC / S&P -27.91% / -4.60% |
WinBCYC / S&P 24.21% / 15.97% |
LoseBCYC / S&P 3.61% / 42.23% |
| 2021-Q41/3 |
WinBCYC / S&P 46.36% / 11.03% |
LoseBCYC / S&P 12.58% / 15.00% |
LoseBCYC / S&P BCYC unavailable / 96.40% |
| 2021-Q31/3 |
WinBCYC / S&P 36.99% / 0.58% |
LoseBCYC / S&P -0.41% / 10.77% |
LoseBCYC / S&P BCYC unavailable / 69.42% |
| 2021-Q21/3 |
LoseBCYC / S&P 1.64% / 8.55% |
WinBCYC / S&P 31.27% / 6.58% |
LoseBCYC / S&P BCYC unavailable / 51.81% |
| 2021-Q12/3 |
WinBCYC / S&P 66.41% / 6.17% |
WinBCYC / S&P 29.52% / -1.06% |
LoseBCYC / S&P BCYC unavailable / 7.39% |
| 2020-Q40/3 |
LoseBCYC / S&P -5.77% / 12.15% |
LoseBCYC / S&P -24.72% / -3.72% |
LoseBCYC / S&P BCYC unavailable / -33.42% |
| 2020-Q32/3 |
WinBCYC / S&P 21.03% / 8.93% |
WinBCYC / S&P 23.45% / -2.04% |
LoseBCYC / S&P BCYC unavailable / -27.10% |
| 2020-Q20/3 |
LoseBCYC / S&P 15.31% / 20.54% |
LoseBCYC / S&P -18.71% / -0.46% |
LoseBCYC / S&P BCYC unavailable / -27.11% |
| 2020-Q11/3 |
WinBCYC / S&P 44.75% / -19.60% |
LoseBCYC / S&P -20.22% / 3.47% |
LoseBCYC / S&P BCYC unavailable / -14.75% |
| 2019-Q40/3 |
LoseBCYC / S&P -17.21% / 9.07% |
LoseBCYC / S&P BCYC unavailable / 5.36% |
LoseBCYC / S&P BCYC unavailable / 2.99% |
| 2019-Q31/3 |
WinBCYC / S&P 13.22% / 1.70% |
LoseBCYC / S&P BCYC unavailable / 5.02% |
LoseBCYC / S&P BCYC unavailable / 0.21% |
| 2019-Q20/3 |
LoseBCYC / S&P BCYC unavailable / 4.30% |
LoseBCYC / S&P BCYC unavailable / 6.64% |
LoseBCYC / S&P BCYC unavailable / 8.65% |
| 2019-Q10/3 |
LoseBCYC / S&P BCYC unavailable / 13.65% |
LoseBCYC / S&P BCYC unavailable / 8.12% |
LoseBCYC / S&P BCYC unavailable / 14.29% |
| 2018-Q40/3 |
LoseBCYC / S&P BCYC unavailable / -13.52% |
LoseBCYC / S&P BCYC unavailable / 9.05% |
LoseBCYC / S&P BCYC unavailable / 18.23% |
| 2018-Q30/3 |
LoseBCYC / S&P BCYC unavailable / 7.71% |
LoseBCYC / S&P BCYC unavailable / 10.21% |
LoseBCYC / S&P BCYC unavailable / 19.06% |
| 2018-Q20/3 |
LoseBCYC / S&P BCYC unavailable / 3.43% |
LoseBCYC / S&P BCYC unavailable / 9.03% |
LoseBCYC / S&P BCYC unavailable / 14.46% |
| 2018-Q10/3 |
LoseBCYC / S&P BCYC unavailable / -0.76% |
LoseBCYC / S&P BCYC unavailable / 7.68% |
LoseBCYC / S&P BCYC unavailable / 12.46% |
| 2017-Q40/3 |
LoseBCYC / S&P BCYC unavailable / 6.64% |
LoseBCYC / S&P BCYC unavailable / 7.03% |
LoseBCYC / S&P BCYC unavailable / 13.82% |
| 2017-Q30/3 |
LoseBCYC / S&P BCYC unavailable / 4.48% |
LoseBCYC / S&P BCYC unavailable / 5.68% |
LoseBCYC / S&P BCYC unavailable / 17.57% |
| 2017-Q20/3 |
LoseBCYC / S&P BCYC unavailable / 3.09% |
LoseBCYC / S&P BCYC unavailable / 4.83% |
LoseBCYC / S&P BCYC unavailable / 17.74% |
| 2017-Q10/3 |
LoseBCYC / S&P BCYC unavailable / 6.07% |
LoseBCYC / S&P BCYC unavailable / 3.67% |
LoseBCYC / S&P BCYC unavailable / 13.32% |
| 2016-Q40/3 |
LoseBCYC / S&P BCYC unavailable / 3.82% |
LoseBCYC / S&P BCYC unavailable / 2.09% |
LoseBCYC / S&P BCYC unavailable / 7.05% |
| 2016-Q30/3 |
LoseBCYC / S&P BCYC unavailable / 3.85% |
LoseBCYC / S&P BCYC unavailable / 0.20% |
LoseBCYC / S&P BCYC unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | BCYC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -41.33% | 20.78% |
| Annualized return | -41.33% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | BCYC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -88.55% | 83.14% |
| Annualized return | -35.17% | 12.86% |
10Y · 2019-05-23 to 2026-08-27
| Metric | BCYC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -63.92% | 319.30% |
| Annualized return | -9.69% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |